MedPath

Bupivacain and Fentanyl, before the start of surgery or before the end of surgery?

Phase 2
Conditions
local analgesia in major gynecologic surgeries.
Unspecified condition associated with female genital organs and menstrual cycle
Registration Number
IRCT201107127013N1
Lead Sponsor
Tabriz Medical University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
50
Inclusion Criteria

(being over 18 years; having indication for major gynecologic surgery)
Exclution criteria: (to have a contraindication for epidural analgesia; to have allergy to local anesthetics; to have mental disorders; organic dysfunctions; previous chronic pain)

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pain severity. Timepoint: 0, 3, 6, 12 and 24 hours after becoming conscious. Method of measurement: using visual pain scoring (VAS) from 0 (without pain) to 10 (severe intolerable pain).;Analgesics administered dose. Timepoint: 0-3-6-12-24 hours after becoming conscious. Method of measurement: Injection count and injection dose in milli or micro grams.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath